Celgene Corporation

(CELG) Trade

By |

Profile

Celgene Corp is a biotech company that discovers, develops, and commercializes therapies designed to treat cancer and immune-inflammatory related diseases. Its registered brands are Abraxane, Istodax, Otezla, Pomalyst, Revlimid, Thalomid, Vidaza.

Contact Information

Website: www.celgene.com
Email: ir@celgene.com
Main Phone: +1 908 673-9000
Address: 86 Morris Avenue
State: NJ
City / Town: Summit
Country: USA
Postal Code: 07901

Issuer Information

Exchange: NGS
CEO: Mark J. Alles
Employees: 7467
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 69.59 $ -0.04 (-0.06%)
Last Price 69.59 Change $ -0.04 Change % -0.06 Tick N/A
Bid 69.58 Bid Size 300.00 Ask 69.59 Ask Size 100.00
Open 69.28 High 70.09 Low 68.91 Prev Close 69.63
Last Trade Volume 6.6 mi 52 Wk Hi 110.81 52 Wk Low 69.36
Market Cap 48.7 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 699,251,840.00 EPS (TTM) 3.95 PE Ratio 18.00 Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 22 112
Number of Buys 12 61
Number of Sells 10 51
Net Activity 49704 125539
Last 10 Buys Shares
Mark J. Alles 1,000
Mark J. Alles 1,000
Michael W. Bonney 1,000
Ernest Mario 1,000
Ernest Mario 1,000
Rodman L. Drake 1,000
Rodman L. Drake 1,000
James J. Loughlin 1,000
Jacqualyn A. Fouse 1,000
Rodman L. Drake 1,000
Last 10 Sell Shares
Michael D. Casey 1,000
James J. Loughlin 1,000
Gilla Kaplan 1,000
James J. Loughlin 1,000
Ernest Mario 1,000
Gilla Kaplan 1,000
Gilla Kaplan 1,000
Terrie Curran 1,000
Gilla Kaplan 1,000
Michael D. Casey 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 163 163 163 163
Low Target Price Estimate 92 92 92 92
Mean Target Price Estimate 120.55 120.55 121.05 120.55
Standard Deviation 24.61 24.61 24.18 24.61
Date of Most Recent Estimate 06/04/18 05/29/18 05/22/18 06/04/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 13 14 15 14
Moderate Buy 1 1 0 0
Hold 12 12 13 13
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.96 1.93 1.93 1.96

News